Nihon Kohden (OTCMKTS:NHNKY) Sees Large Volume Increase – Still a Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw an uptick in trading volume on Thursday . 227,506 shares traded hands during trading, an increase of 907% from the previous session’s volume of 22,601 shares.The stock last traded at $9.3650 and had previously closed at $9.6020.

Wall Street Analyst Weigh In

Separately, UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. One research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Nihon Kohden Stock Performance

The company has a market cap of $1.60 billion, a PE ratio of 18.39 and a beta of 0.39. The firm’s 50 day moving average is $11.19 and its 200-day moving average is $11.26.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, February 5th. The company reported $0.16 earnings per share for the quarter. The business had revenue of $362.86 million for the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.